Lecithin

Synonym(s): phosphatidylcholines, phospholipids, soya lecithin, sunflower lecithin
Nutrient group: vitaminoids, fatty acids

Sources and physiological effects

Dietary sources
Lecithins (also: phosphatidylcholines) are phospholipids and are found in higher amounts in soy products and egg yolk. Sunflower seeds, peanuts, corn or milk also provide phosphatidylcholine.
Physiological effects
Nervous system
  • Essential component of all cell membranes
  • A co-factor involved in building up the myelin layer
Neurotransmitter synthesis
  • Synthesis of acetylcholine
  • Function as second messenger
Fat metabolism
  • Component of bile and counteracts the accumulation of fats in the liver
Detoxification
  • Supports the enzyme activity of the liver for the detoxification of alcohol, environmental toxins and medicines
Blood
  • Influence on blood pressure regulation and platelet aggregation as part of PAF (platelt-activation factors)

Recommended intake

Requirement
Increased demand Pregnancy, growth, alcohol abuse, high consumption of hydrogenated fats, smoking, diseases (such as allergies, diabetes mellitus), multiple sclerosis, neurodermatitis, PMS, rheumatism 
Special group at risk of deficiency Liver disease, dementia, Alzheimer's disease

Detailed information

Lecithin and phospholipids: nutrients with multiple tasks
Lecithin and the phospholipids it contains are phosphoric acids esterified with choline. Due to the choline component, lecithin is of particular physiological importance. As part of the neurotransmitter acetylcholine, it is involved in the transmission of stimuli to the nervous system and as a component of the platelet activating factors it can also have an effect on inflammatory reactions, platelet aggregation and blood pressure(1). In the liver, lecithin leads to a reduction in cholesterol levels and, in the case of a pathologically altered lipoprotein pattern, to its normalization. Lecithin also has liver protection properties and can reduce elevated serum transaminase levels which occur in liver toxicity (2).
Liver protective properties of lecithin
Clinical studies have shown the benefits of supplementing with lecithin in liver function disorders and to protect against liver damaging influences, e.g. from medication or alcohol. Liver parenchyma cells have a very high membrane density. The matrix of these membranes consists of phospholipids. Various studies confirm that an additional supply of lecithin (> 1 g/day) has a favorable influence on membrane properties. In addition, lipotropic functions limit the accumulation of fat in the liver, which promotes cell regeneration in acute liver damage (1) (3). Lecithin also protects the liver tissue against an accumulation of triglycerides and other fats in the cells due to alcohol abuse (4). Lecithin also stimulates the liver's enzymatic systems to degrade and excrete toxins and foreign substances. Phospholipids can also have a positive effect on antioxidative processes by increasing glutathione status (5). The combination of lecithin with B-complex vitamins is superior to the exclusive use of lecithin. In an animal study, for example, an alcohol-induced increase in interleukin-10 and gamma interferon was reduced by the combination of lecithin and B-vitamins and at the same time an 36% increase in reduced glutathione and a 61% increase in superoxide dismutase was documented (6).
Lecithin in psychoneurological symptoms
A targeted supply of lecithin has also been shown to have a positive effect on brain functions. Both learning and memory performance are improved by increased neurotransmitter synthesis in the central nervous system. This applies to both healthy people and people with mild forms of dementia (7).
Phospholipids as protective factors for aging membrane structures
Cell membranes and structures change with age. As a result, aging processes develop and manifest themselves. Lecithin seems to have a protective effect on these processes. According to clinical studies, the subjective quality of life increases in older people after lecithin supplementation (8). In animal experiments, targeted lecithin supplementation was able to attenuate aging processes and age-related hearing loss (9) and thus provides further evidence of the membrane-stabilizing effects. Memory functions can also be significantly improved by regular supplementation (10). For the phospholipids, phosphatidycholine and phosphatidylserine, contained in lecithin, there is a broad base of evidence for benefits such as the promotion of neurotransmitter synthesis which is important for memory (11).
Phospholipids to promote performance in sports
Some experimental studies in animals, but also in humans show that the phospholipids contained in lecithin have a performance-stabilizing or performance-enhancing effect on the organism. Through a short-term supplementation, the performance capacity of runners and cyclists could be increased. This is probably due to improved choline supply and a consequent reduction of the circulating cortisol concentration (12).

Reference values

Nutrigenetik
Bestimmte Nährstoffmängel und deren Einfluss auf die Gene, bezogen auf die damit assoziierten Erkrankungen

Affected gene location

Activity of the affected gene location 

Associated disease 

Nutrient

APOE
 

reduced

Non-alcoholic fatty liver disease

Choline and folate deficiency

FOXA 1
 

reduced

Non-alcoholic fatty liver disease

Choline and folate deficiency

FOXA 2
 

reduced

Non-alcoholic fatty liver disease

Choline and folate deficiency

PPARGA
 

reduced

Non-alcoholic fatty liver disease (13)(14)

Choline and folate deficiency

     
 
     

Deficiency symptoms

Impact on Symptoms
Liver Increase in transaminases and risk of liver damage, obesity and fibrosis
Detoxification Disruption of liver detoxification processes
Nervous system Learning and memory disorders
Kidney Disruption of function

Administration

General mode of administration
 
When
Lecithin should be taken with meals.
Side effects
Nausea may occur in rare cases at high long-term doses (>20 g/d).
Contraindications
No contraindications are known to date.

Interactions

Drug interactions
Anti-tuberculosis agent (e.g. isoniazid) Lecithin may reduce liver function disorders that occur under isoniazid therapy.
Cholesterol-lowering drugs (statins) Lecithin can increase the cholesterol-lowering effect of statins.
Nutrient interactions
None No relevant interactions known to date.

References

References

1) Hahn, A.. 2006. Nahrungsergänzungsmittel und bilanzierte Diäten.
2) Wagner, H., Wiesenauer, M. 2003. Phytotherapie. Phytopharmaka und pflanzliche Homöopathika.
3) LeBlanc, M. J. et al. 2003. Effects of dietary soy bean lecithin on plasma lipid transport and hepatic cholesterol metabolism in rats. J Nutr Biochem. 14(1):40-80.
4) Halsted, C. H. 2004. Nutrition and alcoholic liver disease. Semin Liver Dis. 24(3):289-304.
5) Innis, S. M. et al. 2007. Choline-related supplements improve abnormal plasma methionine-homocysteine metabolites and glutathione status in children with cystic fibrosis. Am J Clin Nutr. 85(3):702-8.
6) Das, S. K. et al. 2007. Effect of lecithin with vitamin- B complex and tocopheryl acetate on long-term effect of ethanol induced immunomodulatory activities. Indian J Exp Biol. 45(8):683-8.
7) Volz, H. P. et al. 2004. Improvement in quality of life in the elderly. Results of a placebo-controlled study on the effects and tolerability of lecithin fluid in patients with impaired cognitive functions. MMW Fortschr Med. 146(Suppl 3-4):99-106.
8) Seidman, M. D. et al. 2002. Influence of lecithin on mitochondrial DNA and age-related hearing loss. Otolaryngol Head Neck Surg. 127(3):138-44.
9) Olbrich, I., Fasching, P. Supplementierung von Mikronährstoffen im Alter. Ernährungsmedizin. 2006 (3); 6-10
10) McDaniel, M. A. et al. 2003. “Brain-specific" nutrients: a memory cure? Nutrition. 19(11-12):957-75.
11) Jäger, R. et al. 2007. Phospholipids and sports performance. : J Int Soc Sports Nutr. 4:5.
12) Bundesminsiterium für Gesundheit. 2008. Universität Wien: Österreichischer Ernährungsbericht.
13) Tryndyak, V. et al. 2012. Interstrain differences in the severity of liver injury induced by choline- and folate-deficient diet in mice are associated with dysregulation of genes involved in lipid metabolism. FASEB J. 26:4592-4602. 
14) Tryndyak, V. P. et al. 2016. Status of hepatic DNA methylome predetermines and modulates the severity of non-alcoholic fatty liver injury in mice. BMC Genomics. 17:298. 

References Interactions
1) Stargrove, M. B. et al. Herb, Nutrient and Drug Interactions: Clinical Implications and Therapeutic Strategies, 1. Auflage. St. Louis, Missouri: Elsevier Health Sciences, 2008.
2) Gröber, U. Mikronährstoffe: Metabolic Tuning –Prävention –Therapie, 3. Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2011.
3) Gröber, U. Arzneimittel und Mikronährstoffe: Medikationsorientierte Supplementierung, 3. aktualisierte und erweiterte Auflage. Stuttgart: WVG Wissenschaftliche Verlagsgesellschaft Stuttgart, 2014.

up